サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1264181

分子品質管理の世界市場の見通し：製品タイプ、分析物タイプ、用途、エンドユーザー別 - 業界の成長と需要の予測（～2030年）

Molecular Quality Controls Market Outlook by Product Type, Analyte Type, Application, End User - Global Industry Growth and Demand Forecast to 2030
出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 280 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
分子品質管理の世界市場の見通し：製品タイプ、分析物タイプ、用途、エンドユーザー別 - 業界の成長と需要の予測（～2030年）
出版日: 2023年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 280 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子品質管理の市場規模は、2022年の1億9,120万米ドルから2030年までに3億1,370万米ドルに達し、今後数年間に6.4％の成長が予測されています。認定臨床検査室の増加により、分子品質管理の需要は今後数年間に増加する見込みです。

当レポートでは、世界の分子品質管理市場について調査分析し、市場力学、地域とセグメントごとの市場収益、競合情勢などの情報を提供しています。

目次

第1章 調査の範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 業界の専門家/KOLの声

第5章 市場の指標

第6章 業界の見通し

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響の分析
  • COVID-19の影響
  • ポーターのファイブフォース分析

第7章 世界市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：地域別（2017年～2030年）

第8章 北米市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：国別（2017年～2030年）

第9章 欧州市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：国別（2017年～2030年）

第10章 アジア太平洋市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：国別（2017年～2030年）

第11章 ラテンアメリカ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：国別（2017年～2030年）

第12章 中東・アフリカ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）
  • 市場収益：国別（2017年～2030年）

第13章 米国市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第14章 カナダ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第15章 ドイツ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第16章 フランス市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第17章 英国市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第18章 イタリア市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第19章 スペイン市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第20章 日本市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第21章 中国市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第22章 インド市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第23章 オーストラリア市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第24章 韓国市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第25章 ブラジル市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第26章 メキシコ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第27章 サウジアラビア市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第28章 南アフリカ市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第29章 アラブ首長国連邦市場

  • 概要
  • 市場収益：製品タイプ別（2017年～2030年）
  • 市場収益：分析物別（2017年～2030年）
  • 市場収益：用途別（2017年～2030年）
  • 市場収益：エンドユーザー別（2017年～2030年）

第30章 競合情勢

  • 市場参入企業とその製品のリスト
  • 主要企業の競合ベンチマーキング
  • 主要企業の製品ベンチマーク
  • 最近の戦略的発展

第31章 企業プロファイル

  • LGC Limited
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • ZeptoMetrix LLC
  • Quidel Corporation
  • Maine Molecular Quality Controls Inc.
  • Microbiologics Inc.
  • Bio-Techne Corporation
  • Qnostics Ltd.
  • Fortress Diagnostics
  • LGC Clinical Diagnostics Inc.
  • Microbix Biosystems Inc.
  • bioMerieux SA
  • Anchor Molecular

第32章 付録

図表

LIST OF FIGURES

  • FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)
  • FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY
  • FIG 9 BARGAINING POWER OF BUYERS
  • FIG 10 BARGAINING POWER OF SUPPLIERS
  • FIG 11 THREAT OF NEW ENTRANTS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M
  • FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 118 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 119 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 120 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 121 QUIDEL CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 122 BIO-TECHNE CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 123 MICROBIX BIOSYSTEMS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 124 BIOMERIEUX SA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
目次
Product Code: 12522

The total size of the molecular quality controls market was USD 191.2 million in 2022, which will reach USD 313.7 million by 2030, propelling at a rate of 6.4% in the years to come, as per a statement by P&S Intelligence.

The independent controls category had the largest share of about 40% in 2022. This is due to the fact that they are produced independently of calibrators, instruments, and reagents, and tests have the supreme sensitivity rate as a result of their tremendously precise, unbiased, and independent valuation of a testing system's or technique's performance.

The single-analyte controls category had a share of over 60%, in 2022, and it will maintain the same in the years to come. This is for the reason that hospitals often use singleplex assays; and with the use of single-analyte, they have benefits for example, easy investigation and understanding and decreased chance of cross-responsiveness, amongst others.

Multi-analyte will witness stable growth rate, about 7%, in the years to come. This can be owing to the progressions in tech and the expansion of new multi-analyte and multi-instrument controls. Clinical labs can save money by the use of these state-of-the-art devices, which integrate frequent instrument-specific controls into a single instrument.

Additionally, by doing away with the necessity for separate quality control actions for each analyte, these controls are responsible for less time consumption.

The diagnostic labs dominated the molecular quality controls market, about 35%, in 2022.

This is due to the fact that the existence of numerous accredited labs in dissimilar regions, which concentrates in services with the use of molecular technology; QC procedures are employed more frequently; regulatory actions are happening more regularly; molecular diagnostics are becoming more expensive; and Alzheimer, diabetes, and cancer cases are increasing, leading to the opening up of numerous labs every year.

North America dominated the industry with about 45%, in 2022. This is because of the high incorporation of leading-edge infra, the enhanced quantity of diagnostic facilities, and the improved count of authorized clinical labs in the region.

Furthermore, the cutting-edge medical facilities in Canada and the U.S., the existence of top manufacturers, and easy access to improved products and techs drive the regional market. In North America, the U.S. has a higher revenue due to large patient population.

Europe follows North America. This is chiefly credited to the snowballing cancer research and related biomarkers and the increasing cancer cases. A study has claimed that there will be a boom in cancer prevalence in Europe, because of the increasing elderly population, as they are prone to long-lasting ailments.

It is because of the increasing count of accredited clinical labs, the demand for molecular quality control will be on the rise in the years to come.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product type
    • 1.4.2. Market size breakdown, by analyte type
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by end user
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

  • 6.1. Market Dynamics
    • 6.1.1. Trends
    • 6.1.2. Drivers
    • 6.1.3. Restraints/challenges
    • 6.1.4. Impact analysis of drivers/restraints
  • 6.2. Impact of COVID-19
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Bargaining power of buyers
    • 6.3.2. Bargaining power of suppliers
    • 6.3.3. Threat of new entrants
    • 6.3.4. Intensity of rivalry
    • 6.3.5. Threat of substitutes

Chapter 7. Global Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product Type (2017-2030)
    • 7.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 7.3. Market Revenue, by Analyte Type (2017-2030)
  • 7.4. Market Revenue, by Application (2017-2030)
  • 7.5. Market Revenue, by End User (2017-2030)
  • 7.6. Market Revenue, by Region (2017-2030)

Chapter 8. North America Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product Type (2017-2030)
    • 8.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 8.3. Market Revenue, by Analyte Type (2017-2030)
  • 8.4. Market Revenue, by Application (2017-2030)
  • 8.5. Market Revenue, by End User (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. Europe Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product Type (2017-2030)
    • 9.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 9.3. Market Revenue, by Analyte Type (2017-2030)
  • 9.4. Market Revenue, by Application (2017-2030)
  • 9.5. Market Revenue, by End User (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. APAC Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product Type (2017-2030)
    • 10.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 10.3. Market Revenue, by Analyte Type (2017-2030)
  • 10.4. Market Revenue, by Application (2017-2030)
  • 10.5. Market Revenue, by End User (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. LATAM Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product Type (2017-2030)
    • 11.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 11.3. Market Revenue, by Analyte Type (2017-2030)
  • 11.4. Market Revenue, by Application (2017-2030)
  • 11.5. Market Revenue, by End User (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. MEA Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product Type (2017-2030)
    • 12.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 12.3. Market Revenue, by Analyte Type (2017-2030)
  • 12.4. Market Revenue, by Application (2017-2030)
  • 12.5. Market Revenue, by End User (2017-2030)
  • 12.6. Market Revenue, by Country (2017-2030)

Chapter 13. U.S. Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product Type (2017-2030)
    • 13.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 13.3. Market Revenue, by Analyte Type (2017-2030)
  • 13.4. Market Revenue, by Application (2017-2030)
  • 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Canada Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product Type (2017-2030)
    • 14.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 14.3. Market Revenue, by Analyte Type (2017-2030)
  • 14.4. Market Revenue, by Application (2017-2030)
  • 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. Germany Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product Type (2017-2030)
    • 15.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 15.3. Market Revenue, by Analyte Type (2017-2030)
  • 15.4. Market Revenue, by Application (2017-2030)
  • 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. France Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product Type (2017-2030)
    • 16.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 16.3. Market Revenue, by Analyte Type (2017-2030)
  • 16.4. Market Revenue, by Application (2017-2030)
  • 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. U.K. Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product Type (2017-2030)
    • 17.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 17.3. Market Revenue, by Analyte Type (2017-2030)
  • 17.4. Market Revenue, by Application (2017-2030)
  • 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Italy Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product Type (2017-2030)
    • 18.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 18.3. Market Revenue, by Analyte Type (2017-2030)
  • 18.4. Market Revenue, by Application (2017-2030)
  • 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Spain Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product Type (2017-2030)
    • 19.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 19.3. Market Revenue, by Analyte Type (2017-2030)
  • 19.4. Market Revenue, by Application (2017-2030)
  • 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. Japan Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product Type (2017-2030)
    • 20.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 20.3. Market Revenue, by Analyte Type (2017-2030)
  • 20.4. Market Revenue, by Application (2017-2030)
  • 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. China Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product Type (2017-2030)
    • 21.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 21.3. Market Revenue, by Analyte Type (2017-2030)
  • 21.4. Market Revenue, by Application (2017-2030)
  • 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. India Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product Type (2017-2030)
    • 22.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 22.3. Market Revenue, by Analyte Type (2017-2030)
  • 22.4. Market Revenue, by Application (2017-2030)
  • 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. Australia Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product Type (2017-2030)
    • 23.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 23.3. Market Revenue, by Analyte Type (2017-2030)
  • 23.4. Market Revenue, by Application (2017-2030)
  • 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. South Korea Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product Type (2017-2030)
    • 24.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 24.3. Market Revenue, by Analyte Type (2017-2030)
  • 24.4. Market Revenue, by Application (2017-2030)
  • 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Brazil Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product Type (2017-2030)
    • 25.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 25.3. Market Revenue, by Analyte Type (2017-2030)
  • 25.4. Market Revenue, by Application (2017-2030)
  • 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Mexico Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product Type (2017-2030)
    • 26.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 26.3. Market Revenue, by Analyte Type (2017-2030)
  • 26.4. Market Revenue, by Application (2017-2030)
  • 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. Saudi Arabia Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product Type (2017-2030)
    • 27.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 27.3. Market Revenue, by Analyte Type (2017-2030)
  • 27.4. Market Revenue, by Application (2017-2030)
  • 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. South Africa Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product Type (2017-2030)
    • 28.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 28.3. Market Revenue, by Analyte Type (2017-2030)
  • 28.4. Market Revenue, by Application (2017-2030)
  • 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. U.A.E. Market

  • 29.1. Overview
  • 29.2. Market Revenue, by Product Type (2017-2030)
    • 29.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 29.3. Market Revenue, by Analyte Type (2017-2030)
  • 29.4. Market Revenue, by Application (2017-2030)
  • 29.5. Market Revenue, by End User (2017-2030)

Chapter 30. Competitive Landscape

  • 30.1. List of Market Players and their Offerings
  • 30.2. Competitive Benchmarking of Key Players
  • 30.3. Product Benchmarking of Key Players
  • 30.4. Recent Strategic Developments

Chapter 31. Company Profiles

  • 31.1. LGC Limited
    • 31.1.1. Business overview
    • 31.1.2. Product and service offerings
  • 31.2. Thermo Fisher Scientific Inc.
    • 31.2.1. Business overview
    • 31.2.2. Product and service offerings
    • 31.2.3. Key financial summary
  • 31.3. Bio-Rad Laboratories Inc.
    • 31.3.1. Business overview
    • 31.3.2. Product and service offerings
    • 31.3.3. Key financial summary
  • 31.4. F. Hoffmann-La Roche Ltd.
    • 31.4.1. Business overview
    • 31.4.2. Product and service offerings
    • 31.4.3. Key financial summary
  • 31.5. ZeptoMetrix LLC
    • 31.5.1. Business overview
    • 31.5.2. Product and service offerings
  • 31.6. Quidel Corporation
    • 31.6.1. Business overview
    • 31.6.2. Product and service offerings
    • 31.6.3. Key financial summary
  • 31.7. Maine Molecular Quality Controls Inc.
    • 31.7.1. Business overview
    • 31.7.2. Product and service offerings
  • 31.8. Microbiologics Inc.
    • 31.8.1. Business overview
    • 31.8.2. Product and service offerings
  • 31.9. Bio-Techne Corporation
    • 31.9.1. Business overview
    • 31.9.2. Product and service offerings
    • 31.9.3. Key financial summary
  • 31.10. Qnostics Ltd.
    • 31.10.1. Business overview
    • 31.10.2. Product and service offerings
  • 31.11. Fortress Diagnostics
    • 31.11.1. Business overview
    • 31.11.2. Product and service offerings
  • 31.12. LGC Clinical Diagnostics Inc.
    • 31.12.1. Business overview
    • 31.12.2. Product and service offerings
  • 31.13. Microbix Biosystems Inc.
    • 31.13.1. Business overview
    • 31.13.2. Product and service offerings
    • 31.13.3. Key financial summary
  • 31.14. bioMerieux SA
    • 31.14.1. Business overview
    • 31.14.2. Product and service offerings
    • 31.14.3. Key financial summary
  • 31.15. Anchor Molecular
    • 31.15.1. Business overview
    • 31.15.2. Product and service offerings

Chapter 32. Appendix

  • 32.1. Abbreviations
  • 32.2. Sources and References
  • 32.3. Related Reports